Your browser doesn't support javascript.
loading
Receptor occupancy measurement of anti-PD-1 antibody drugs in support of clinical trials.
Fu, Jie; Wang, Fang; Dong, Li-Hou; Xing, Mei-Jing; Cheng, Xue; Wei, Su; Xu, Jing-Zhi; Han, Min; Dong, Kelly; Song, Hai-Feng.
Afiliação
  • Fu J; State Key Laboratory of Proteomics, Beijing Institute of Lifeomics, Beijing 102206, PR China.
  • Wang F; New Drug Evaluation Platform, National Engineering Research Center for Protein Drugs, Beijing 102206, PR China.
  • Dong LH; New Drug Evaluation Platform, National Engineering Research Center for Protein Drugs, Beijing 102206, PR China.
  • Xing MJ; Immunoassay Department, United-Power Pharma Tech Co. Ltd, Beijing 102206, PR China.
  • Cheng X; State Key Laboratory of Proteomics, Beijing Institute of Lifeomics, Beijing 102206, PR China.
  • Wei S; New Drug Evaluation Platform, National Engineering Research Center for Protein Drugs, Beijing 102206, PR China.
  • Xu JZ; Immunoassay Department, United-Power Pharma Tech Co. Ltd, Beijing 102206, PR China.
  • Han M; Immunoassay Department, United-Power Pharma Tech Co. Ltd, Beijing 102206, PR China.
  • Dong K; Immunoassay Department, United-Power Pharma Tech Co. Ltd, Beijing 102206, PR China.
  • Song HF; Immunoassay Department, United-Power Pharma Tech Co. Ltd, Beijing 102206, PR China.
Bioanalysis ; 11(14): 1347-1358, 2019 Jul.
Article em En | MEDLINE | ID: mdl-31393160

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Análise Química do Sangue / Ensaios Clínicos como Assunto / Receptor de Morte Celular Programada 1 / Anticorpos Monoclonais Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Análise Química do Sangue / Ensaios Clínicos como Assunto / Receptor de Morte Celular Programada 1 / Anticorpos Monoclonais Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article